Inventiva Sa (IVA): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 15,2 US Dollar | 11 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 236.220.651 | 3,74 | 4,2 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Inventiva Sa
Mitarbeiter 87
Handelsplatz NASDAQ
Ticker Symbol IVA
IPO Datum 2020-07-10
Adresse 50 rue de Dijon, Daix, France, 21121
Webseite https://inventivapharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Andrew Obenshain | Chief Executive Officer |
| 2 | Dr. Pierre Broqua Ph.D. | Co-Founder |
| 3 | Mr. Jean Volatier | Executive VP Finance & Corporate Social Responsibility |
| 4 | Dr. Martine Zimmermann Pharm.D. | Executive VP of Regulatory Affairs & Quality Assurance and Head of Regulatory Affairs |
| 5 | Mr. Jason A. Campagna M.D., Ph.D. | President of Research & Development and Chief Medical Officer |
| 6 | Mr. Axel-Sven Malkomes | Chief Financial Officer |
| 7 | Mr. Christopher Benecchi M.B.A. | Chief Operating Officer |
| 8 | Ms. Susan Coles | Chief Legal Officer |
| 9 | Ms. Pamela Herbster | Chief People Officer |
| 10 | Ms. Pascaline Clerc Ph.D. | Executive Vice President of External & Corporate Affairs |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Caligan Partners LP | 3,46% | 25,79 Mio. USD |
| 2 | Samsara BioCapital, LLC | 2,67% | 19,95 Mio. USD |
| 3 | Nantahala Capital Management, LLC | 2,27% | 16,98 Mio. USD |
| 4 | Paradigm Biocapital Advisors LP | 1,69% | 12,64 Mio. USD |
| 5 | Andera Partners | 1,54% | 11,48 Mio. USD |
| 6 | ADAR1 Capital Management LLC | 1,53% | 11,40 Mio. USD |
| 7 | Millennium Management LLC | 1,49% | 11,10 Mio. USD |
| 8 | Trails Edge Capital Partners, LP | 1,13% | 8,40 Mio. USD |
| 9 | Franklin Templeton Inc | 1,12% | 8,35 Mio. USD |
| 10 | Squadron Capital Management LLC | 1,03% | 7,69 Mio. USD |
| 11 | SymBiosis Capital Partners, LLC | 1,00% | 7,44 Mio. USD |
| 12 | Woodline Partners LP | 0,98% | 7,34 Mio. USD |
| 13 | Aberdeen Group PLC | 0,98% | 7,29 Mio. USD |
| 14 | UBS Group AG | 0,98% | 7,28 Mio. USD |
| 15 | BOOTHBAY FUND MANAGEMENT, LLC | 0,85% | 6,33 Mio. USD |
| 16 | Patient Square Capital LP | 0,83% | 6,22 Mio. USD |
| 17 | NEXTBio Capital Management LP | 0,76% | 5,65 Mio. USD |
| 18 | Citadel Advisors Llc | 0,76% | 5,64 Mio. USD |
| 19 | Ameriprise Financial Inc | 0,72% | 5,36 Mio. USD |
| 20 | Point72 Asset Management, L.P. | 0,71% | 5,32 Mio. USD |